Introduction to Managing Toxicity From Immunotherapy
Exploring Managing Toxicity From Immunotherapy reveals several interesting facts. Martin Gore, PhD, FRCP, CBE from the Royal Marsden NHS Foundation, London, UK discusses the risks from
Managing Toxicity From Immunotherapy Comprehensive Overview
Omid Hamid, MD, leads the panel discussion on the safety of nivolumab and Dr. Medina is an Assistant Professor of medicine in the Division of Medical Oncology at the University of Colorado Anschutz ... Panelists Benjamin P. Levy, MD, and Sarah B. Goldberg, MD, MPH, outline the importance of
Physicians who are dealing with gynecological tumors have a limited experience of how to deal with the complications and
Summary & Highlights for Managing Toxicity From Immunotherapy
- Yevgeniy Semenov, MD, Massachusetts General Hospital, Boston, MA, provides a brief overview of skin
- Host: Jacob Sands, MD Guest: Aliyah Pabani, MD Lung cancer patients undergoing
- Panelists Mark A. Socinski, MD; John V. Heymach, MD, PhD; Howard L. Kaufman, MD; Dean F. Bajorin, MD; and Jared M. Weiss, ...
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
- Tune in as melanoma clinician Melissa Wilson, PA-C, MPAS, breaks down how to
Stay tuned for more updates related to Managing Toxicity From Immunotherapy.